©The Author(s) 2020.
World J Gastrointest Surg. Apr 27, 2020; 12(4): 159-170
Published online Apr 27, 2020. doi: 10.4240/wjgs.v12.i4.159
Published online Apr 27, 2020. doi: 10.4240/wjgs.v12.i4.159
Table 1 Demographic, clinical, and operative characteristics of patients with neuroendocrine liver metastases undergoing resection
| NELM (n = 669) | |
| Median age in years, n (IQR) | 60 (51-67) |
| Male gender, n (%) | 341 (51) |
| ASA classification, n (%) | |
| I | 2 (0.3) |
| II | 143 (21) |
| III | 459 (69) |
| IV | 61 (9) |
| Median BMI (kg/m2), n (IQR) | 27.4 (24-32) |
| Comorbidities/preoperative | |
| > 10% loss body weight in last 6 mo, n (%) | 30 (4.4) |
| Diabetes mellitus with oral agents or insulin, n (%) | 115 (17) |
| Current smoker within one yr, n (%) | 79 (12) |
| Severe chronic obstructive pulmonary disease, n (%) | 9 (0.3) |
| Congestive heart failure in 30 d before surgery, n (%) | 5 (0.7) |
| Hypertension requiring medications, n (%) | 326 (49) |
| Viral hepatitis, n (%) | 13 (1.9) |
| Preoperative biliary stent, n (%) | 13 (1.9) |
| Ascites within 30 d, n (%) | 3 (0.4) |
| Preoperative sepsis, n (%) | 2 (0.3) |
| Steroid use for a chronic condition, n (%) | 20 (3) |
| Bleeding disorders, n (%) | 18 (2.6) |
| Preoperative transfusion, n (%) | 3 (0.4) |
| Neoadjuvant therapy, n (%) | 119 (17.7) |
| Patients with concomitant procedure (%) | 304 (45.4) |
| Total number of cholecystectomy | 193 (28.8) |
| Total number of small/large bowel resection | 135 (20.2) |
| Total number of partial pancreatectomy | 23 (3.4) |
| Operative approach, n (%) | |
| Open | 546 (82) |
| Laparoscopic | 113 (17) |
| Robotic | 10 (1) |
| Liver resection type, n (%) | |
| Trisegmentectomy | 42 (6) |
| Right hepatectomy | 99 (15) |
| Left hepatectomy | 52 (8) |
| Partial lobectomy | 476 (71) |
| Size of metastatic lesion, n (%) | |
| < 2 cm | 152 (23) |
| 2-5 cm | 303 (45) |
| > 5 cm | 181 (27) |
| Unknown | 33 (5) |
| Number of metastatic lesions, n (%) | |
| < 2 | 298 (45) |
| 3-5 | 168 (26) |
| > 5 | 166 (27) |
| Unknown | 37 (2) |
| Concurrent partial liver resections, n (%) | |
| 0 | 205 (30.6) |
| 1-5 | 385 (57.5) |
| 6-9 | 44 (6.6) |
| > 10 | 5 (0.7) |
| Unknown | 30 (4.5) |
| Liver texture, n (%) | |
| Normal | 190 (28) |
| Congested | 8 (1) |
| Cirrhotic | 12 (2) |
| Fatty | 57 (9) |
| Unknown | 402 (60) |
| Median optime in minutes, n (IQR) | 232 (179-297) |
| Pringle maneuver during resection, n (%) | 161 (24) |
| Biliary reconstruction, n (%) | 14 (2) |
| Intraoperative ablation, n (%) | 205 (30) |
| Drain placement | 253 (38) |
- Citation: Scoville SD, Xourafas D, Ejaz AM, Tsung A, Pawlik T, Cloyd JM. Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases. World J Gastrointest Surg 2020; 12(4): 159-170
- URL: https://www.wjgnet.com/1948-9366/full/v12/i4/159.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i4.159